Role of Ultrasound in Evaluation of Pulmonary Manifestations of COVID-19 Using Computed Tomography as A Gold Standard | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 105, Volume 89, Issue 2, October 2022, Page 6771-6778 PDF (718.92 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2022.270811 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Rania Mostafa Al-Molla; Ashraf Ali Mohamed Ali Mansour; Osama Abd Allah Dawoud; Marwa Elsayed Abd Elhamed | ||||
| Abstract | ||||
| Background: In critical care medicine, lung ultrasonography (LUS) has become more widely utilized as a trustworthy method for assessing lung diseases. Since COVID-19 pneumonia lesions have a predominant peripheral distribution, LUS detection is more appropriate. Objective: This study was aimed to assess the role of LUS in early diagnosis of COVID-19, as well as severity assessment of COVID-19 patients using CT chest as a gold standard. Patients and methods: Patients in this prospective cohort study were complaining of symptoms raising suspicion of SARS-CoV-2 infection and referred from chest emergency departments. Ultra-sound and CT were done for all patients and finding were correlated in the two modalities with estimation of the severity score. Results: out of 242 patients with CT chest findings positive for COVID-19 infection, 232 patients demonstrated positive LUS findings for COVID-19. Our study revealed the sensitivity of LUS up to (99.15%), specificity (100%), PPV (100%), NPV (80%) and accuracy (99.17%). Conclusion: It could be concluded that LUS could show pulmonary manifestations indicative of COVID-19 in symptomatic patients with high diagnostic accuracy comparable to CT chest. | ||||
| Keywords | ||||
| CT; US; COVID-19; Diagnosis | ||||
|
Statistics Article View: 127 PDF Download: 232 |
||||
